Up to 50% of the people who have died from COVID-19 had metabolic and vascular
disorders. Notably, there are many direct links between COVID-19 and the metabolic and …

The prevalence of diabetes in people with coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

Background: Coronavirus disease 19 (COVID-19) is regarded as an independent risk factor
for acute ischemic stroke (AIS) due to the induction of endothelial dysfunction, coagulopathy …

The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …

Type 2 diabetes mellitus (T2DM) is a worldwide major health burden and heart failure (HF)
is the most common cardiovascular (CV) complication in affected patients. Therefore …

It has become widely accepted that inflammation is a driving force behind a variety of
chronic diseases, such as cardiovascular disease, diabetes, kidney disease, cancer …

Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …

Background and Aims During the current Coronavirus Disease 2019 (COVID-19) pandemic,
patients with diabetes face disproportionately more. This study was performed to clarify anti …

Importance/Background: The coronavirus disease (COVID-19) pandemic is a critical public
health issue. Evidence has shown that metformin favorably influences COVID-19 outcomes …